RNS1 Jul 2025 07:36
London South East
Share PricesGenip Plc Share PriceGenip Plc Share Regulatory NewsGenIP Secures First UK Academic Clients
Pinned to quick picksGenip Plc Regulatory News (GNIP)
GNIP Share Price
GNIP Share
Price
GNIP Share News
GNIP Share
News
GNIP Share Chat
GNIP Share
Chat
GNIP Share Trades
GNIP Share
Trades
GNIP Live RNS
GNIP
Live RNS
1
Genip Plc Information
Add GNIP to Timeline
Add GNIP to Timeline
Add GNIP to Watchlist
Add GNIP to Watchlist
Add GNIP to Alert
Add GNIP to Alert
Buy GNIP Shares
Buy GNIP Shares
Share Price Information for Genip Plc (GNIP)
London Stock Exchange
Share Price:
34.00
Bid:
0.00
Ask:
0.00
Change:
0.00 (0.00%)
Spread: 0.00 (0.00%)Open: 0.00High: 0.00Low: 0.00Prev. Close: 34.00
GNIP Live PriceLast checked at 07:35:55
GenIP Secures First UK Academic Clients
Today 07:00
RNS Number : 0781P
GenIP PLC
01 July 2025
1 July 2025
GenIP Plc
("GenIP" or the "Company")
GenIP Secures First UK Academic Clients
GenIP Plc, a technology business providing Generative Artificial Intelligence (GenAI) services to help research organisations and corporations commercialise their innovations, is pleased to announce that it has broken into the UK academic technology transfer market by securing its first contracts with leading UK-based research institutions.
Following a productive month attending key UK industry events, the Company has been engaged by a prominent university known for its applied research and industry collaboration and a second public research university recognised for its innovation pipeline across engineering, health sciences, and digital technologies.
Building upon recent expansion into Chile and Brazil, GenIP's entry into the UK academic technology transfer market marks a significant milestone for its global growth strategy and demonstrates the Company's growing role as a trusted partner to leading research institutions.
Melissa Cruz, CEO of GenIP, commented:
"Securing our first UK academic clients is a significant milestone for GenIP and a clear signal of growing demand for our AI-powered technology analytics platform. We're proud to support leading research institutions that are actively investing in commercialising their innovation pipeline.
"These engagements come at a time of strong commercial momentum for GenIP. Following our participation in key industry events across the UK and Europe, we've experienced a material increase in inbound interest from both academic and corporate organisations. These new contracts and several other active commercial discussions underscore our traction in markets that value fast, scalable, and high-quality evaluation tools.
"GenIP is scaling rapidly, increasing adoption across universities, corporate R&D teams, and government innovation programmes. Our platform combines generative AI with expert analysis to help clients make faster, more informed decisions abou